Overview

Effect of High-Dose Vitamin D3 in Smokers and Non-Smokers With and Without HIV

Status:
Terminated
Trial end date:
2018-10-15
Target enrollment:
Participant gender:
Summary
Supplementation with vitamin D improves HIV+ macrophages phagocytosis in vitro. There is evidence to suggest that administering vitamin D can in fact improve immune function in individuals. The study will evaluate the impact of high dose vitamin D in HIV+ smokers' and HIV- smokers' in vivo. The primary goal is to improve innate immune host response to infection in patients already at high risk by virtue of HIV and smoking status.
Phase:
Phase 1
Details
Lead Sponsor:
Emory University
Treatments:
Cholecalciferol
Ergocalciferols
Vitamin D
Vitamins